954240-89-2 Usage
Uses
Used in Chemical Reactions and Organic Synthesis:
5-BROMO-3-NITROPYRIDINE-2-CARBOXYLIC ACID is used as a key intermediate in chemical reactions and organic synthesis processes. Its bromine and nitro functional groups allow for a wide range of chemical transformations, making it a valuable building block for the development of new compounds and materials.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 5-BROMO-3-NITROPYRIDINE-2-CARBOXYLIC ACID is used as a starting material for the synthesis of various drug candidates. Its unique structure and functional groups can be exploited to design and develop new therapeutic agents with potential applications in treating various diseases and medical conditions.
Used in Agricultural Industry:
5-BROMO-3-NITROPYRIDINE-2-CARBOXYLIC ACID may also have potential applications in the agricultural industry. Its chemical properties and reactivity can be utilized in the development of new agrochemicals, such as pesticides and herbicides, to improve crop protection and yield.
Check Digit Verification of cas no
The CAS Registry Mumber 954240-89-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,4,2,4 and 0 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 954240-89:
(8*9)+(7*5)+(6*4)+(5*2)+(4*4)+(3*0)+(2*8)+(1*9)=182
182 % 10 = 2
So 954240-89-2 is a valid CAS Registry Number.
InChI:InChI=1/C6H3BrN2O4/c7-3-1-4(9(12)13)5(6(10)11)8-2-3/h1-2H,(H,10,11)
954240-89-2Relevant academic research and scientific papers
TRICYCLIC COMPOUNDS AND COMPOSITIONS AS KINASE INHIBITORS
-
Page/Page column 105, (2017/07/06)
The present invention provides compounds of Formula (A): (I) as described herein, and salts thereof, and therapeutic uses of these compounds for treatment of disorders associated with Raf kinase activity. The invention further provides pharmaceutical compositions comprising these compounds, and compositions comprising these compounds and a therapeutic co-agent, and methods of using the compositions and combinations to treat conditions including cancers.
